Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Hematology|October 26, 2012
Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in miceYuki Kagiyama, Jiro Kitaura, Katsuhiro Togami, et al.
Blood|October 29, 2009
Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemiaFumio Nakahara, Mamiko Sakata-Yanagimoto, Yukiko Komeno, et al.
Blood|October 2, 2010
Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT modelsNaoko Kato, Jiro Kitaura, Noriko Doki, et al.
Molecular and Cellular Biology|July 1, 2015
SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA SplicingYukiko Komeno, Yi-Jou Huang, Jinsong Qiu, et al.
American Journal of Hematology|January 1, 2003
Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluidMasahito Kawazu, Yoshinobu Kanda, Susumu Goyama, et al.
American Journal of Hematology|February 28, 2003
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor originYukiko Komeno, Yoshinobu Kanda, Koji Kandabashi, et al.
Blood|February 24, 2009
Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemiaKazuko Miyazaki, Norimasa Yamasaki, Hideaki Oda, et al.
The Journal of Experimental Medicine|June 23, 2010
TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injuryYoshinori Yamanishi, Jiro Kitaura, Kumi Izawa, et al.
Leukemia Research|April 11, 2006
Antineoplastic effect of a single oral dose of the novel Flt3 inhibitor KRN383 on xenografted human leukemic cells harboring Flt3-activating mutationsUichi Nishiyama, Tetsuya Yoshino, Masako Ozai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A randomized controlled trial to compare once- versus twice-daily filgrastim for mobilization of peripheral blood stem cells from healthy donorsYukiko Komeno, Yoshinobu Kanda, Tamae Hamaki, et al.
Pageof 4